Patent ductus arteriosus with persistent pulmonary artery hypertension after transcatheter closure

Jianqi Feng,1,2 Xiangqing Kong,1 Yanhui Sheng,1 Rong Yang1 1Department of Cardiology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, 2Department of Cardiology, the Second Affiliated Hospital of XuZhou Medical University, XuZhou, Jiangsu, People’s Republic of...

Full description

Saved in:
Bibliographic Details
Main Authors: Feng JQ (Author), Kong XQ (Author), Sheng YH (Author), Yang R (Author)
Format: Book
Published: Dove Medical Press, 2016-11-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_e9f3368c992343e68a59c787fcc75a61
042 |a dc 
100 1 0 |a Feng JQ  |e author 
700 1 0 |a Kong XQ  |e author 
700 1 0 |a Sheng YH  |e author 
700 1 0 |a Yang R  |e author 
245 0 0 |a Patent ductus arteriosus with persistent pulmonary artery hypertension after transcatheter closure 
260 |b Dove Medical Press,   |c 2016-11-01T00:00:00Z. 
500 |a 1178-203X 
520 |a Jianqi Feng,1,2 Xiangqing Kong,1 Yanhui Sheng,1 Rong Yang1 1Department of Cardiology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, 2Department of Cardiology, the Second Affiliated Hospital of XuZhou Medical University, XuZhou, Jiangsu, People&rsquo;s Republic of China Objectives: To observe the change in pulmonary artery systolic pressure (PASP) of patients with persistent pulmonary arterial hypertension (PAH) after patent ductus arteriosus (PDA) occlusion.Background: After occlusion of PDA in patients with PAH, some patients still tend to suffer from persistent PAH.Methods: A chest X-ray, an electrocardiogram, and an echocardiogram were performed on nine patients at 24 hours, 1 and 6 months, and 1 year serially.Results: There was a significant fall (P<0.05) in mean PASP after occlusion (to 59.3&plusmn;12.7 mmHg). However, the aortic pressure and systemic arterial oxygen saturation changed slightly (P>0.05). During the follow up, there was a further fall in the PASP in five patients (No 1, 5, 6, 7, and 8). Four patients (No 2, 3, 4, and 8) showed the evidence of worsening PAH and were treated with sildenafil. Patient 2 died from acute right heart failure after a period of 11 months from the time of transcatheter closure, triggered by pulmonary infection.Conclusion: Some patients with borderline hemodynamic data with PDA and PAH can deteriorate or keep sustained PAH after PDA closure. The treatment of permanent closure to these patients must be cautious. Keywords: patent ductus arteriosus (PDA), transcatheter closure (TCC), pulmonary artery hypertension, follow-up 
546 |a EN 
690 |a Patent ductus arteriosus (PDA) 
690 |a Transcatheter closure (TCC) 
690 |a pulmonary artery hypertension 
690 |a follow-up 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Therapeutics and Clinical Risk Management, Vol Volume 12, Pp 1609-1613 (2016) 
787 0 |n https://www.dovepress.com/patent-ductus-arteriosus-with-persistent-pulmonary-artery-hypertension-peer-reviewed-article-TCRM 
787 0 |n https://doaj.org/toc/1178-203X 
856 4 1 |u https://doaj.org/article/e9f3368c992343e68a59c787fcc75a61  |z Connect to this object online.